Quantum BioPharma Statistics Share Statistics Quantum BioPharma has n/a
shares outstanding. The number of shares has increased by 56.58%
in one year.
Shares Outstanding n/a Shares Change (YoY) 56.58% Shares Change (QoQ) 51.48% Owned by Institutions (%) n/a Shares Floating 2.56M Failed to Deliver (FTD) Shares 4,126 FTD / Avg. Volume 1.53%
Short Selling Information The latest short interest is 136.54K, so 4.7% of the outstanding
shares have been sold short.
Short Interest 136.54K Short % of Shares Out 4.7% Short % of Float 4.85% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -0.29 and the forward
PE ratio is -30.62.
Quantum BioPharma's PEG ratio is
0.01.
PE Ratio -0.29 Forward PE -30.62 PS Ratio 0 Forward PS 6 PB Ratio 0.36 P/FCF Ratio -0.61 PEG Ratio 0.01
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Quantum BioPharma.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 1.8,
with a Debt / Equity ratio of 0.07.
Current Ratio 1.8 Quick Ratio 1.79 Debt / Equity 0.07 Debt / EBITDA -0.06 Debt / FCF -0.12 Interest Coverage -339.16
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee n/a Employee Count undefined Asset Turnover 0 Inventory Turnover 3.99
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by 213.03% in the
last 52 weeks. The beta is 1.62, so Quantum BioPharma's
price volatility has been higher than the market average.
Beta 1.62 52-Week Price Change 213.03% 50-Day Moving Average 21.1 200-Day Moving Average 9.83 Relative Strength Index (RSI) 64.22 Average Volume (20 Days) 268,866
Income Statement
Revenue n/a Gross Profit n/a Operating Income -16.14M Net Income -14.2M EBITDA -13.69M EBIT -14.87M Earnings Per Share (EPS) -12.49
Full Income Statement Balance Sheet The company has 6M in cash and 824.92K in
debt, giving a net cash position of 5.17M.
Cash & Cash Equivalents 6M Total Debt 824.92K Net Cash 5.17M Retained Earnings -172.11M Total Assets 14.87M Working Capital -412.6K
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -6.88M
and capital expenditures 0, giving a free cash flow of -6.88M.
Operating Cash Flow -6.88M Capital Expenditures n/a Free Cash Flow -6.88M FCF Per Share -6.05
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields QNTM does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast Currently there are no analyst rating for QNTM.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Aug 15, 2024. It was a
backward
split with a ratio of 1:65.
Last Split Date Aug 15, 2024 Split Type backward Split Ratio 1:65
Scores Altman Z-Score -15.93 Piotroski F-Score 1
